搜索临床试验以:RSV 疫苗 (GSK3844766A) 无佐剂高剂量
总计180个结果
-
GlaxoSmithKline完全的
-
GlaxoSmithKline完全的呼吸道合胞病毒感染台湾, 西班牙, 美国, 意大利, 加拿大, 巴拿马, 墨西哥, 波兰
-
Duke UniversityBoston Medical Center; Centers for Disease Control and Prevention; Children's Hospital Medical...完全的
-
Marshfield Clinic Research FoundationCenters for Disease Control and Prevention完全的
-
Oriol ManuelUniversity of Zurich; University Hospital, Geneva; University Hospital, Basel, Switzerland; University... 和其他合作者完全的
-
Novavax完全的
-
Duke UniversityJohns Hopkins University; Centers for Disease Control and Prevention完全的
-
University of Colorado, DenverColorado Clinical & Translational Sciences Institute完全的
-
Stanford UniversityNational Institute of Allergy and Infectious Diseases (NIAID)完全的
-
Jiangsu Province Centers for Disease Control and...Beijing Institute of Biotechnology; Tianjin Cansino Biotechnology Inc完全的
-
Stanford UniversityNational Institute of Allergy and Infectious Diseases (NIAID)完全的
-
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Shanghai Public Health Clinical Center; Beijing Simoonrecord Pharmaceutical Information Consulting...完全的
-
Curevo IncGreen Cross Corporation; Mogam Biotechnology Research Institute主动,不招人
-
Tongji UniversityShanghai Pharmaceuticals Holding Co., Ltd主动,不招人
-
CanSino Biologics Inc.Henan Center for Disease Control and Prevention完全的
-
Sanofi Pasteur, a Sanofi Company完全的
-
Sanofi Pasteur, a Sanofi Company完全的
-
Brigham and Women's HospitalPatient-Centered Outcomes Research Institute; National Heart, Lung, and Blood Institute (NHLBI) 和其他合作者完全的
-
GlaxoSmithKline完全的呼吸道合胞病毒感染芬兰, 西班牙, 英国, 美国, 泰国, 巴西, 加拿大, 巴拿马, 意大利, 哥伦比亚, 墨西哥, 波兰, 火鸡
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI)完全的